Table 1

Patients characteristic with regard to the inclusion groups
Characteristics Placebo (n = 59) NAC (n = 55)
Age (years) 78.2 ±11.8 78.1 ± 12.0
Sex (M/F) 29/30 28/27
BMI (kg/m2) 24.4 ± 4.6 25.0 ± 4.8
Diabetes 11 (19%) 15 (27%)
Blood pressure (mmHg)
   Diastolic 69.1 ± 11.7 67.0 ± 17.2
   Systolic 129.5 ± 20.8 132.9 ± 22.5
Contrast medium (mL) 117.7 ± 3.2 117.4 ± 1.8
Creatinine (μmol/L) 133.5 ± 34.8 132.4 ± 34.8
Cystatin C (mg/L) 1.9 ± 0.5 1.9 ± 0.6
eGFR (MDRD) (ml/min/1.73) 41.7 ± 1.2 42.7 ± 1.2
Antibiotics 16 (27%) 16 (29%)
Angiotensin-converting enzyme inhibitor (ACE-1 inhibitor) 28 (48%) 25 (45%)
Non-steroidal antiinflammatory drugs (NSAIDS) 1 (2%) 5 (9%)
Diuretics 27 (46%) 25 (45%)

Poletti et al.

Poletti et al. BMC Nephrology 2013 14:119   doi:10.1186/1471-2369-14-119

Open Data